Ketamine vs. Spravato: What’s the Difference and Which One Is Right for You?

In recent years, ketamine-based treatments have emerged as powerful options for people struggling with depression, anxiety, PTSD, and other mood-related conditions—especially when traditional medications haven’t provided enough relief. As awareness grows, so do the questions. Many people hear about ketamine therapy and Spravato® and wonder: Are they the same? How are they different? And which one might be best for me?

While both treatments come from the same original compound and share some similarities, they differ in important ways—from how they’re administered to how they’re accessed and covered by insurance. Understanding these differences can help you make a more informed decision about your mental health care.

What Is Ketamine Therapy?

Ketamine has been used in medical settings for decades, originally as an anesthetic. Over the last twenty years, research has shown that at lower, controlled doses, ketamine can have rapid antidepressant effects and may help reduce symptoms of anxiety, trauma, and suicidal thinking. Unlike traditional antidepressants, which often take weeks to work, ketamine can create noticeable shifts in mood for some individuals within hours or days.

In mental health treatment, ketamine is typically administered in one of several forms:

Intramuscular (IM) injection
Intravenous (IV) infusion
Sublingual lozenge or tablet
Nasal spray (compounded versions, not Spravato)

These treatments are generally provided in specialized clinical settings under medical supervision. Some programs combine ketamine with psychotherapy or integrative support to help process insights that may arise during the experience.

Ketamine is considered an “off-label” treatment for mental health, meaning it’s not specifically FDA-approved for depression, though it is widely used in clinical practice with growing research support.

What Is Spravato?

Spravato® is a prescription nasal spray derived from esketamine, a component of ketamine. It is FDA-approved specifically for treatment-resistant depression and for depression with acute suicidal ideation in certain cases. Because of its FDA approval, Spravato is typically covered by insurance when medical criteria are met.

Spravato is administered in a clinical setting under supervision. Patients self-administer the nasal spray while being monitored by a healthcare provider. After dosing, there is a required observation period—usually around two hours—to ensure safety and stability before leaving the clinic.

Treatment with Spravato generally follows a structured schedule: more frequent sessions at the beginning, then tapering to maintenance treatments as symptoms improve.

Key Differences Between Ketamine and Spravato

Although both treatments come from the same parent compound, several distinctions may influence which option feels more appropriate.

Regulation and Approval:
Spravato is FDA-approved and follows standardized treatment protocols. Ketamine therapy, while supported by research and widely used, is considered off-label for depression and may vary more between providers.

Insurance Coverage:
Spravato is often covered by insurance for qualifying diagnoses, which can make it more financially accessible. Ketamine treatments are usually self-pay, though some clinics offer financing or package pricing.

Method of Administration:
Ketamine therapy may be administered through injection, infusion, or lozenge, depending on the provider. Spravato is only available as a nasal spray delivered in a monitored clinical environment.

Structure of Treatment:
Spravato follows a standardized dosing schedule and monitoring requirements. Ketamine therapy can be more flexible, with treatment plans tailored to individual needs and responses.

Integration and Support:
Some ketamine programs incorporate psychotherapy, coaching, or integration sessions alongside treatment. Spravato programs may also include therapeutic support, but the structure can vary by provider. At Blue Lotus Wellness, we provide therapeutic integration services for both treatments.

Which One Is “Better”?

There isn’t a universal answer to which treatment is better. The right option depends on your history, symptoms, goals, and practical considerations like cost, insurance coverage, and scheduling.

For some people, the structure and insurance coverage of Spravato make it an accessible and effective choice. For others, the flexibility and individualized approach of ketamine therapy feel more aligned with their needs. Both treatments aim to support mood stabilization and create new neural pathways that may help reduce depressive symptoms and improve emotional resilience.

A thoughtful consultation with a qualified provider can help you explore which option fits your circumstances.

Who Might Consider These Treatments

Ketamine-based therapies are typically considered for individuals who:
Have not responded adequately to traditional antidepressants
Experience treatment-resistant depression
Live with persistent anxiety, PTSD, or mood disorders
Need more rapid symptom relief
Are seeking alternatives when standard approaches feel insufficient

These treatments are not usually first-line options. They are often part of a broader mental health plan that may include therapy, lifestyle support, and ongoing medical care.

What to Expect From Treatment

Both ketamine and Spravato can create temporary changes in perception, mood, and awareness during sessions. Some people describe feeling deeply relaxed, introspective, or emotionally open. Others notice shifts in perspective or relief from persistent negative thought patterns.

After treatment, many programs emphasize integration—making sense of insights and supporting the nervous system as it adjusts. The goal is not only symptom relief, but also lasting improvement in mood and functioning.

Questions to Ask When Deciding

If you’re considering ketamine or Spravato, it can help to ask:

What is my diagnosis and treatment history?
What kind of structure or flexibility do I prefer?
What are the financial and insurance considerations?
What kind of support or integration is available?
What outcomes am I hoping for?

These questions can guide you toward a treatment plan that feels informed and aligned.

Final Thoughts

Exploring new treatment options can feel both hopeful and overwhelming. Ketamine and Spravato represent important advances in mental health care, offering new pathways for people who haven’t found relief through traditional methods. Understanding the differences between them can help you move forward with clarity and confidence.

​The most important step is not choosing the “perfect” option—it’s starting a conversation about what support might help you feel better. With thoughtful guidance and a personalized approach, many people find meaningful relief and renewed possibility through these treatments.